Operator: Greetings. Welcome to IntelGenx’s Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
SAINT LAURENT, Quebec, Sept. 19, 2023 IntelGenx Corp. today provided a regulatory update on Buprenorphine Buccal Film, for which an abbreviated new drug application has been filed with the.
SAINT LAURENT, Quebec, April 13, 2023 IntelGenx Technologies Corp. today announced various changes to its management team. Following the planned retirement of its founder and CEO, Horst. | April 13, 2023
The Food and Drug Administration (“FDA” or the “Agency”) user fee negotiations may have hit an iceberg, but it did not sink all the legislative riders that accompanied this summer’s.